Allergan Inc., Endo Pharmaceuticals Solutions, Inc., and Supernus Pharmaceuticals, Inc. pursue a patent infringement complaint against Watson, Watson Laboratories, Inc. — Florida, and Watson Pharma, Inc.
In June 2009, the Company…
Allergan Inc.’s consolidated patent infringement suit against Exela PharmSci Inc. and Apotex Inc. is ongoing in the U.S. District Court for the District of Delaware.
In February 2007, the Company and…
Allergan Inc.’s patent infringement complaint against Barr Laboratories, Inc., is pending in the U.S. District Court for the District of Delaware.
In March 2009, the Company received a paragraph 4 invalidity…
An Oct. 12, 2010 trial date for Allergan Inc.’s complaint in the U.S. District Court for the Central District of California alleging infringement of U.S. Patent Nos. 6,262,105, 7,351,404, and…
Allergan Inc.’s patent infringement complaint against Hi-Tech Pharmacal Co., is pending in the U.S. District Court for the Eastern District of Texas.
In April 2009, the Company received paragraph 4 invalidity…
Apotex Inc.’s bid for the rehearing of Allergan Inc. and Roche Palo Alto LLC’s suit for the alleged infringement of U.S. Patent No. 5,110,493, is pending with the U.S. Court…
The U.S. District Court for the District of Delaware has scheduled a trial date for March 9, 2009, in Allergan Inc.’s consolidated patent infringement suit against Exela PharmSci Inc. and…
The U.S. District Court for the Central District of California has scheduled a trial date on Nov. 3, 2009, for Allergan Inc.’s complaint against eight defendants, alleging the infringement of…